Does CLORAZEPATE Cause Interstitial lung disease? 14 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Interstitial lung disease have been filed in association with CLORAZEPATE (Clorazepate Dipotassium). This represents 0.8% of all adverse event reports for CLORAZEPATE.
14
Reports of Interstitial lung disease with CLORAZEPATE
0.8%
of all CLORAZEPATE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Interstitial lung disease From CLORAZEPATE?
Of the 14 reports, 3 (21.4%) required hospitalization, and 5 (35.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLORAZEPATE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does CLORAZEPATE Cause?
Coma (203)
Toxicity to various agents (173)
Somnolence (142)
Off label use (109)
Drug abuse (98)
Hypotension (96)
Intentional overdose (94)
Drug ineffective (92)
Fall (92)
Anxiety (78)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CLORAZEPATE Alternatives Have Lower Interstitial lung disease Risk?
CLORAZEPATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN
CLORAZEPATE vs CLOTHIAPINE
CLORAZEPATE vs CLOTIAZEPAM
CLORAZEPATE vs CLOTRIMAZOLE
CLORAZEPATE vs CLOXACILLIN